comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Park rehovot - Page 1 : comparemela.com
Evogene : Q1 2024 Consolidated Financial Statements
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF.
Rehovot
Hamerkaz
Israel
United-states
Brazil
Washington
Canada
Israeli
America
Lavie-bio
Yaron-eldad
Foods-ltd
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF.
Israel
Washington
United-states
Rehovot
Hamerkaz
American
Elran-haber
Rachel-pomerantz-gerber
Lavie-bio
Gal-markel
Yaron-eldad
Commission-file-number
Evogene : Immediate Report of Meeting - MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF.
Israel
Rehovot
Hamerkaz
United-states
Washington
American
Israeli
Nir-nimrodi
Oded-shoseyov
Dan-falk
Ofer-haviv
Sarit-firon
Evogene : Reports Receipt of Nasdaq Minimum Bid Price Notification -September 21, 2023 at 07:07 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF.
Rehovot
Hamerkaz
Israel
Ness-ziona
United-states
Washington
Yaron-eldad
Exchange-commission
Biomica-ltd
Evogene-ltd
Lavie-bio-ltd
Nasdaq-stock-market
Evogene : ) - Form 6-K
July 17, 2023 Evogene Ltd. 13 Gad Feinstein Street, Park Rehovot, Rehovot P.O. Box 4173, Ness.
Israel
Rehovot
Hamerkaz
Ness-ziona
State-of-israel
Israeli
Evogene-ltd
Company-the-board
Israel-the-company
Exchange-commission
Company-the-offering
vimarsana © 2020. All Rights Reserved.